Emergent BioSolutions Inc.

NYSE:EBS

8.1 (USD) • At close December 20, 2024
Bedrijfsnaam Emergent BioSolutions Inc.
Symbool EBS
Munteenheid USD
Prijs 8.1
Beurswaarde 438,892,020
Dividendpercentage 0%
52-weken bereik 1.42 - 15.1
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Richard S. Lindahl M.B.A.
Website https://www.emergentbiosolutions.com

An error occurred while fetching data.

Over Emergent BioSolutions Inc.

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and

Vergelijkbare Aandelen

Pediatrix Medical Group, Inc. logo

Pediatrix Medical Group, Inc.

MD

14.09 USD

Nevro Corp. logo

Nevro Corp.

NVRO

3.79 USD

U.S. Physical Therapy, Inc. logo

U.S. Physical Therapy, Inc.

USPH

91.31 USD

Glaukos Corporation logo

Glaukos Corporation

GKOS

150.88 USD

Warby Parker Inc. logo

Warby Parker Inc.

WRBY

25.18 USD

Taro Pharmaceutical Industries Ltd. logo

Taro Pharmaceutical Industries Ltd.

TARO

42.975 USD

Arcus Biosciences, Inc. logo

Arcus Biosciences, Inc.

RCUS

15.5 USD

Avanos Medical, Inc. logo

Avanos Medical, Inc.

AVNS

16.08 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)